Amytrx Therapeutics Inc. Jan 2024 a Series of CGF2021 LLC (CIK: 0002023260) EDGAR, Information, Filings... CompaniesBIO.Com

Amytrx Therapeutics Inc. Jan 2024 a Series of CGF2021 LLC

Mailing address
2093 PHILADELPHIA PIKE, 5885, CLAYMONT, Delaware, 19703
Phone
(360) 946-0604
State location
Delaware
State of incorporation
Delaware
Fiscal year end
December 31
SIC
N/A
Filings
N/A

Amytrx Therapeutics Inc. Jan 2024 a Series of CGF2021 LLC (CIK: 0002023260) is an American company incorporated in the state of Delaware. Head office is located at 2093 PHILADELPHIA PIKE, 5885, CLAYMONT, Delaware, 19703. Work in the industry N/A. Amytrx Therapeutics Inc. Jan 2024 a Series of CGF2021 LLC is a public company and trade via Over-The-Counter (OTC).

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Amytrx Therapeutics Inc. Jan 2024 a Series of CGF2021 LLC

Filings	Format	Description	Filed/Effective	File/Film Number
D	Document	Acc-no: 0002023260-24-000001 (33 Act) Size: KB	May-15-2024	021-513381 24949289

Recent 20 filings. View all Amytrx Therapeutics Inc. Jan 2024 a Series of CGF2021 LLC filings

Overall rating 5.0

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Amytrx Therapeutics Inc. Jan 2024 a Series of CGF2021 LLC overview
Amytrx Therapeutics Inc. Jan 2024 a Series of CGF2021 LLC job
Amytrx Therapeutics Inc. Jan 2024 a Series of CGF2021 LLC stock
Amytrx Therapeutics Inc. Jan 2024 a Series of CGF2021 LLC ownership
Amytrx Therapeutics Inc. Jan 2024 a Series of CGF2021 LLC CEO
Amytrx Therapeutics Inc. Jan 2024 a Series of CGF2021 LLC documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.